• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Ups and downs--and ups in the antiviral therapy of HIV infection.HIV感染抗病毒治疗的起伏——以及进展
Genitourin Med. 1996 Feb;72(1):2-5. doi: 10.1136/sti.72.1.2.
2
Current management of HIV infection in children.
Pediatr Ann. 1993 Jul;22(7):428-35. doi: 10.3928/0090-4481-19930701-09.
3
Nucleoside therapy for HIV infection--some answers, many questions.用于治疗HIV感染的核苷疗法——一些答案，诸多问题。
N Engl J Med. 1992 Aug 27;327(9):639-41. doi: 10.1056/NEJM199208273270912.
4
Managing HIV disease after Delta.德尔塔变异株出现后的艾滋病管理
BMJ. 1996 Mar 2;312(7030):521-2. doi: 10.1136/bmj.312.7030.521.
5
[Anti-HIV therapy (1987-1994): from nothing to confusion].[抗逆转录病毒疗法（1987 - 1994年）：从无到乱]
Med Clin (Barc). 1995 Apr 1;104(12):463-7.
6
Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
Pediatr Infect Dis J. 1993 Jun;12(6):513-22.
7
Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.对于感染HIV-1的免疫功能低下的成年人，联合用药可能比单独使用齐多夫定效果更好。
Commun Dis Rep CDR Wkly. 1995 Oct 20;5(42):209.
8
Didanosine (DDI) alone is now considered the first-line therapy for symptomatic children infected with the human immunodeficiency virus (HIV).目前，去羟肌苷（DDI）单独使用被视为感染人类免疫缺陷病毒（HIV）的有症状儿童的一线治疗方法。
J Am Osteopath Assoc. 1996 Jun;96(6):339.
9
[Current developments in antiviral chemotherapy. Part 4: Foscarnet, zidovudine, didanosine].[抗病毒化疗的当前进展。第4部分：膦甲酸钠、齐多夫定、去羟肌苷]
Fortschr Med. 1994 May 10;112(13):190-1.
10
Anti-HIV therapy lowers risk of AIDS, death in patients with intermediate-stage HIV disease.抗艾滋病毒疗法降低中期艾滋病毒疾病患者患艾滋病和死亡的风险。
AIDS Patient Care. 1995 Dec;9(6):303.

引用本文的文献

1
The Medication Attribution Scale: perceived effects of antiretrovirals and quality of life.药物归因量表：抗逆转录病毒药物的感知效果与生活质量
Qual Life Res. 1998 Apr;7(3):205-14. doi: 10.1023/a:1024913425993.

本文引用的文献

1
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.齐多夫定用于无症状HIV感染者且CD4+细胞计数大于每立方毫米400个的人群。欧洲-澳大利亚协作组。
N Engl J Med. 1993 Jul 29;329(5):297-303. doi: 10.1056/NEJM199307293290501.
2
Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.协和试验的初步分析。协和协调委员会。
Lancet. 1993 Apr 3;341(8849):889-90. doi: 10.1016/0140-6736(93)93096-j.
3
Surrogate markers in AIDS and cancer trials.
Stat Med. 1994;13(13-14):1423-35; discussion 1437-40. doi: 10.1002/sim.4780131318.
4
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
JAMA. 1994 Aug 10;272(6):437-42.
5
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).对有艾滋病进展高风险的无症状HIV感染受试者每日两次服用齐多夫定：一项随机、双盲、安慰剂对照研究。欧洲-澳大利亚协作组（研究017）
AIDS. 1994 Mar;8(3):313-21. doi: 10.1097/00002030-199403000-00004.
6
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group.1型人类免疫缺陷病毒感染的无症状血友病患者每日两次服用齐多夫定的随机双盲、安慰剂对照试验。欧洲-澳大利亚血友病协作研究组
Br J Haematol. 1994 Jan;86(1):174-9. doi: 10.1111/j.1365-2141.1994.tb03270.x.
7
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.无症状人类免疫缺陷病毒感染中齐多夫定治疗相关生活质量的评估。艾滋病临床试验组。
N Engl J Med. 1994 Mar 17;330(11):738-43. doi: 10.1056/NEJM199403173301102.
8
A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.齐多夫定治疗后，对人类免疫缺陷病毒感染患者使用去羟肌苷或扎西他滨的对比试验。艾滋病临床研究特里·贝恩社区项目。
N Engl J Med. 1994 Mar 10;330(10):657-62. doi: 10.1056/NEJM199403103301001.
9
Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).艾滋病临床试验临床终点选择的考量。特里·贝恩艾滋病临床研究社区项目（CPCRA）。
Stat Med. 1994;13(19-20):2107-25. doi: 10.1002/sim.4780131919.
10
HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.体内HIV群体动力学：对基因变异、发病机制及治疗的影响
Science. 1995 Jan 27;267(5197):483-9. doi: 10.1126/science.7824947.

Ups and downs--and ups in the antiviral therapy of HIV infection.

作者信息

Weller I V, Williams I

机构信息

Department of Sexually Transmitted Diseases, University College London Medical School.

出版信息

Genitourin Med. 1996 Feb;72(1):2-5. doi: 10.1136/sti.72.1.2.

DOI:10.1136/sti.72.1.2
PMID:8655161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1195581/
Abstract
摘要